Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. - Wikidata - awgldk - TriplyDB

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

http://www.wikidata.org/entity/Q37692742

about

Clinical features of schizophrenia with enhanced carbonyl stress.Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.Pathogenesis of beta(2)-microglobulin amyloidosis: role of monocytes/macrophages.Protective role of metallothionein in acute lung injury induced by bacterial endotoxin.Carbonyl stress and diabetic complications.Oxidative stress and cellular stress response in diabetic nephropathy.Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.beta(2)-microglobulin: from physiology to amyloidosis.Lipid glycation and protein glycation in diabetes and atherosclerosis.Understanding the complex mechanisms of β2-microglobulin amyloid assembly.Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration.Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum.Effect of methylglyoxal modification on the structure and properties of human small heat shock protein HspB6 (Hsp20)Oxidative stress-associated rise of hepatic protein glycation increases inflammatory liver injury in uncoupling protein-2 deficient mice.Extension of A beta2M amyloid fibrils with recombinant human beta2-microglobulin.Glomerulosclerosis in captive cheetahs (Acinonyx jubatus).Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies.Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.Functional mapping of human sound and carious enamel and dentin with Raman spectroscopy.Aqueous Extract of Gynura Bicolor Attenuated Hepatic Steatosis, Glycative, Oxidative, and Inflammatory Injury Induced by Chronic Ethanol Consumption in Mice.Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice.Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice.In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.Cleaved beta 2-microglobulin partially attains a conformation that has amyloidogenic features.Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway.Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.Glycation and post-translational processing of human interferon-gamma expressed in Escherichia coli.Content of nitric oxide and glycative compounds in cured meat products-Negative impact upon health.Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)Modification of β2-microglobulin with D-glucose or 3-deoxyglucosone inhibits Aβ2M amyloid fibril extensionin vitro β2-microglobulin amyloidosis Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases

P2860

Q34048575-4076A7BF-A121-4F23-8669-58A053651264 Q34193025-41D59C2F-19EB-4EA5-9FB9-A6F292B1355D Q34193036-3C08B331-0732-4D15-A94B-5F67AB1573D8 Q35536410-5120B223-EC26-4CD6-84C1-5C6A8DA1C8AD Q35576070-550BF45F-B379-4B3C-B98E-63BB7DB8D30E Q36259336-3F14821A-537C-4DF2-B9AA-B520EC67F561 Q37376119-1099ED33-DD0D-4DF7-8E45-03D8B97682CF Q37573510-5797E98B-3F7C-42B6-8B41-BE786AD0D948 Q37801315-AE716C31-8B2C-4818-AED8-A464EAD00A9F Q37877295-F49C7170-FAAC-4ED4-9428-2E7DCEC069AF Q38006722-68102879-6A10-42B6-B8E0-236CF63B8C05 Q38151611-DCBD71F9-49FF-407B-A770-72891521CDEB Q38752287-EE4CAA35-3B9B-4EFB-A61A-F7E4B2FB0A94 Q39598754-51131CB6-B318-4AC0-AB16-90C52E1A1AEB Q40428494-30F2F6F5-7DB3-4F5B-9B0E-F4CD1FF08129 Q42715059-CC618C55-22BC-46DF-BE55-B0D1504C7283 Q43109146-65F889B0-CCA5-453D-B54E-99508DB3A379 Q43568860-A4728C95-0359-4C3E-B926-8338D5B63CE2 Q44125361-5114C796-9354-4FEB-B600-98E51A8057F2 Q44844852-DB05650D-2CF4-472D-A39B-397053B59394 Q44978432-6837A728-DC62-4CFD-9717-4DCB810D2C68 Q45345323-D1E89ACF-A5CD-4839-8835-9A9B0C6BFE27 Q46288071-AF9E7B2A-2678-4231-B4A2-0E10C87072CC Q46568515-10E9A177-B528-4842-A060-C05F73540338 Q46697121-2D0E138C-15B1-4DA5-8FFE-2E209BECF31F Q46698193-5CFD2108-7EE1-4790-8511-1700C4EDCFF3 Q46724329-A1BF875F-590F-431A-8453-27A372B8E082 Q46901315-AFABC63C-BD50-44C9-8F50-B7D7030D4FB8 Q46925426-6FB2FBF0-D552-48E4-8525-6D64C9820FF0 Q47730385-99051702-8D4F-4444-B805-4A20C86599CB Q51331971-9E40FF6A-E698-4230-8424-D4115A8E2221 Q54126440-04D0BEDD-4028-4B0A-93BD-1D0C679401E8 Q54517575-200CA75B-4D97-4213-A22D-81F945B14AEF Q55355854-0C4E3692-B151-4C48-8363-97DA264D41BA Q57259461-53BD9E46-C4FB-4193-A14B-A2830816BEE5 Q58125053-E2D3883F-8739-4C44-9598-D1DD02A5CD40 Q58290563-4397E6D8-C6B2-4A71-AA93-2D8FFA4B41A9 Q58711702-D75169DA-7652-49B7-BA15-1BA1007D1F22

P2860

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

http://www.wikidata.org/entity/Q37692742

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Identification of pentosidine ...... dialysis-related amyloidosis.

@en

Identification of pentosidine ...... dialysis-related amyloidosis.

@nl

type

label

Identification of pentosidine ...... dialysis-related amyloidosis.

@en

Identification of pentosidine ...... dialysis-related amyloidosis.

@nl

prefLabel

Identification of pentosidine ...... dialysis-related amyloidosis.

@en

Identification of pentosidine ...... dialysis-related amyloidosis.

@nl

P1433

Q37692742-7A72FB95-46C1-4169-A351-F2619D0EF8E3

P1476

Q37692742-22FF6E8F-767F-40EE-BB29-F8F2B9087F5E

P2093

Q37692742-1A5C16BC-893A-436D-A259-C665F7F97134

Q37692742-2E2D3433-85B0-407C-B791-FEE40419D162

Q37692742-6F1E3DCF-3F30-469A-8ECA-ED09AE3478C2

Q37692742-7B2EE1AB-0C69-4A9B-8DA6-6A1291A15CD6

Q37692742-8602BBE4-62F5-4009-9213-AAB0018C2E09

Q37692742-93291725-4867-46F4-AC15-C807B4105CE6

Q37692742-C404BFD5-EB66-43FF-826C-98957189F605

Q37692742-FAF2DF41-06B8-4CE3-AAD1-EADD032485F0

P2860

Q37692742-08BF4770-E97F-45E9-8368-2D3D228AA980

Q37692742-142C76F6-5697-4F6D-9AF1-A9E2E02C8922

Q37692742-16EF3105-9BC0-4444-828F-B7AA005E63F1

Q37692742-17F9B6E4-9C87-4C75-AB13-953239E9C6F2

Q37692742-1F419F8F-968A-49BC-A4DB-9286BE1DE240

Q37692742-4D37CFC3-9270-4E62-8AC6-40023D0384D9

Q37692742-57B1A527-4316-48D6-951C-E8D4B6F7B38F

Q37692742-63EF5AAF-C309-499E-B3D5-636F0AE3A337

Q37692742-6C991F95-D58F-4A25-A06A-F60538B142B4

Q37692742-700A547B-05DD-4F65-B20C-5AF3AB35A9E6

P304

Q37692742-11C00D14-E6F2-4ECA-9446-45BA1EB52530

P31

Q37692742-84D15320-306F-4291-80FC-DCC3C2B8CEFF

P356

Q37692742-CB464276-B922-4A7B-B07E-076A6CC3D832

P407

Q37692742-F5E0DFDF-CD8E-45D9-9B34-F7CFDA1DF5F4

P433

Q37692742-27826138-3C9C-4CE4-9FDD-B5AF87B692BD

P478

Q37692742-233BB84B-2978-454A-98EE-761D44AF5802

P577

Q37692742-E76F0854-4FA7-4195-955B-A0287620B8E5

P5875

Q37692742-55DD5F54-3687-4B8F-9B41-0DA64F9EF9E4

P698

Q37692742-52C8FDBD-7BE5-47C1-B606-16A09D85DF4E

P921

Q37692742-C5C9E075-7EA1-4179-AA82-671F3207E806

Q37692742-E006E19D-3071-4FCE-902B-4F3842E78348

P932

Q37692742-AF3F309B-6DE7-40ED-9170-B02EC2AF355F

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Identification of pentosidine ...... dialysis-related amyloidosis.

@en

P2093

K Maeda

http://www.w3.org/2001/XMLSchema#string

M Hara

http://www.w3.org/2001/XMLSchema#string

R Kawai

http://www.w3.org/2001/XMLSchema#string

S Horiuchi

http://www.w3.org/2001/XMLSchema#string

S Taneda

http://www.w3.org/2001/XMLSchema#string

T Miyata

http://www.w3.org/2001/XMLSchema#string

V M Monnier

http://www.w3.org/2001/XMLSchema#string

Y Ueda

http://www.w3.org/2001/XMLSchema#string

P2860

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

In vitro formation of amyloid fibrils from intact beta 2-microglobulin

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis.

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor

Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors.

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

P304

2353-2358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.6.2353

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242906651

http://www.w3.org/2001/XMLSchema#string

P698

8637877

http://www.w3.org/2001/XMLSchema#string

P921

P932

39800

http://www.w3.org/2001/XMLSchema#string